Updates in Thrombosis and Anticoagulation

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

D. Garcia

CHEST 2024 Insights: Post COVID Cardiac Complications

CHEST Annual Meeting Insights

N. Ramesh

How do I Recognize and Treat the VEXAS Syndrome?

Cleveland Clinic Rheumatology

P. Grayson

Cancer-Associated Thrombosis: Anticoagulant Dose and Duration Consid…

BMFcases

T. Bat, M. Carrier

Management of Simultaneous Venous and Arterial Thromboembolic Disease

Scripps Health

J. May

Cancer-Associated Thrombosis: Defining, Risk Assessment, and Prognos…

BMFcases

T. Bat, M. Carrier

Risk for Developing VTE in Pts With Compound Heterozygosity of FVL a…

Cleveland Clinic Taussig Cancer Institute

G. Gerber

Perioperative Considerations for Anticoagulation With Mechanical Dev…

James Douketis

Medical Jeopardy: 2024 Update

Scripps Health

J. Diamant

EHA 2024 Insights: Low-Molecular-Weight Heparin and VTE in Newly Dia…

Insights from 2024 EHA Annual Meeting

M. Lauw

Cancer-Associated Thrombosis: Which Anticoagulant and Why

BMFcases

T. Bat, M. Carrier

Cancer-Associated Thrombosis: Choosing Factor XI and XIa Inhibitors

BMFcases

T. Bat, M. Carrier

Cancer-Associated Thrombosis: Assessing Bleeding Risk and When to Pr…

BMFcases

T. Bat, M. Carrier

2023 ISTH Insights: "The EVE Trial - Extending VTE Secondary Prevent…

Robert McBane

Venous Thromboembolism Prophylaxis in Newly Diagnosed MM

Vanderbilt University Medical Center (VUMC)

M. Baljevic

Cancer-Associated VTE: Dynamic Modelling and Prediction With DNA Liq…

Yale Cancer Center

A. Pine

Diagnosis and Goals of Therapy in PV

Northwestern Medicine Oncology and Hematology

B. Stein

Role of Anticoagulants and Antiplatelet Agents for Patients With COV…

CHEST 2022 Coverage

V. Balasubramanian

Five Things Every Internist Should Know About Anticoagulants

McMaster University Department of Medicine

S. Mithoowani

Current Review of Benign Hematology and Coagulopathy

Indy Hematology Review

C. Kessler